Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae

Neisseria gonorrhoeae is a high-priority pathogen of concern due to the growing prevalence of resistance development against approved antibiotics. Herein, we report the anti-gonococcal activity of ethoxzolamide, the FDA-approved human carbonic anhydrase inhibitor. Ethoxzolamide displayed an MIC50, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Nader S. Abutaleb (Author), Ahmed E. M. Elhassanny (Author), Alessio Nocentini (Author), Chad S. Hewitt (Author), Ahmed Elkashif (Author), Bruce R. Cooper (Author), Claudiu T. Supuran (Author), Mohamed N. Seleem (Author), Daniel P. Flaherty (Author)
Format: Book
Published: Taylor & Francis Group, 2022-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items